Shares of Silk Road Medical fell after the company lowered its full-year revenue outlook.
The stock was down 33% to $9.42 in after-hours trading, after falling 0.7% at Tuesday’s close. Shares are down 74% this year.
The Sunnyvale, Calif.-based medical-device company said it projected full-year revenue of $170 million to $174 million, compared with prior guidance of $180 million to $184 million. Analysts polled by FactSet expect full-year revenue of $181.7 million.
Silk Road said based on preliminary results it expects third-quarter revenue of $44.4 million, missing the $46.3 million forecast by analysts polled by FactSet.
The company also announced Chief Executive Erica Rogers would retire after a successor is appointed.